Skip to content

Clinical trials

Phase 3 Joint Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Joint Diseases Phase: Phase 3 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20083
20093
20102
20152
20163
20173
20181
20201
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie8
Regeneron Pharmaceuticals3
Kolon TissueGene, Inc.2
Organogenesis2
Pfizer2
UCB Pharma2
Amgen1
Bayer1
Bristol-Myers Squibb1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Joint Diseases25
Arthritis18
Musculoskeletal Diseases16
Arthritis, Rheumatoid10
Rheumatic Diseases9
Osteoarthritis5
Osteoarthritis, Knee4
Arthritis, Psoriatic3
Genetic Diseases, Inborn3
Gout3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.